Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Premier Sponsors:  

Beckman Coulter Life Sciences 

Boston Healthcare


Charles River Discovery




Silicon Biosystems   




  View All Sponsors 

Cambridge Healthtech Institute’s Eighth Annual

Personalized Diagnostics

Establishing Clinical Sequencing as a Routine Diagnostic Tool

February 20-22, 2017 | Moscone North Convention Center | San Francisco, CA
Part of the 24th International Molecular Medicine Tri-Conference


NGS and other molecular tools are being employed for opportunities enabled by immuno-oncology, liquid biopsy and combination therapy. The Eighth Annual Personalized Diagnostics conference will offer practical insights for building gene panels, understanding the changing landscape of reimbursement and regulation, and deploying clinical sequencing for immunotherapy, liquid biopsy and a host of diseases not limited to oncology. Recently uncovered genetic mutations in a patient's own cancer can guide a personalized treatment strategy. Plan to attend and learn what is being done to further our understanding of disease and combat it with targeted approaches.

Who should attend: CEO, CMO, CSO, Director, Medical Director, President, Research Scientist, Vice President from Oncology, Cancer Biology, Hematology, Diagnostic Service, Pathology, Medical Affairs, Innovation, Technology Development, Lab Medicine & Pathology, Bioengineering, Family Medicine

Topics will include, but are not limited to:

  • Benchmarking genetic variants in cancer
  • Guiding immunotherapy with NGS
  • Translating circulating biomarkers into clinical use
  • Advancing prenatal molecular diagnostics
  • Understanding tumor heterogeneity and resistance in the context of cancer treatment
  • Preparing exome sequencing for molecular diagnosis
  • Employing big data in personalized medicine
  • Factoring in the changing reimbursement and regulation of NGS for diagnostics

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is July 29, 2016.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: (+1) 781-972-5464
E: clingham@healthtech.com

Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com